KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Shares Outstanding (Weighted Average) (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Shares Outstanding (Weighted Average) for 7 consecutive years, with $356.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) fell 7.62% to $356.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $356.3 million through Dec 2025, down 7.62% year-over-year, with the annual reading at $356.3 million for FY2025, 7.62% down from the prior year.
  • Shares Outstanding (Weighted Average) hit $356.3 million in Q4 2025 for GoodRx Holdings, down from $360.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $414.7 million in Q1 2022 to a low of $356.3 million in Q4 2025.
  • Historically, Shares Outstanding (Weighted Average) has averaged $396.4 million across 5 years, with a median of $408.5 million in 2021.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): surged 77.53% in 2021 and later fell 8.0% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $410.0 million in 2021, then rose by 0.7% to $412.9 million in 2022, then dropped by 0.62% to $410.3 million in 2023, then fell by 5.99% to $385.7 million in 2024, then dropped by 7.62% to $356.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for GDRX at $356.3 million in Q4 2025, $360.7 million in Q3 2025, and $356.6 million in Q2 2025.